miR-100-5p Enhances Cell Cycle-Mediated Chemoresistance by Modulating the CTDSPL/pRB/E2F1 Signaling Pathway in Oxaliplatin-Resistant Colorectal Cancer Cells.
miR-100-5p 通过调节奥沙利铂耐药结直肠癌细胞中的 CTDSPL/pRB/E2F1 信号通路增强细胞周期介导的化疗耐药性。
期刊:Oncology Research
影响因子:4.1
doi:10.32604/or.2026.073080
Chen Yen-Pin, Baskaran Rathinasamy, Devi Hema Sri, Singh Chaouhan Hitesh, Lin Yu-Jung, Shibu Marthandam Asokan, Kuo Wei-Wen, Liao Shih-Chieh, Chen Ming-Cheng, Wang Tso-Fu, Li Chi-Cheng, Ho Tsung-Jung, Shih Tzu-Ching, Lin Shinn-Zong, Huang Chih-Yang